From: Mesenchymal stem cell treatment for chronic renal failure
Disease | Source | Dose | Route | Mechanism of action | Side effects | Reference |
---|---|---|---|---|---|---|
Diabetic nephropathy | Mice bone marrow | 0.5 × 106 | Intravenous | Engraftment/direct effect | None | [11] |
Diabetic nephropathy | Human bone marrow | 2 × 106 | Intracardiac | Engraftment/direct effect | None | [12] |
Partial nephrectomy | Rat bone marrow | 1 × 106 | Intravenous | Paracrine effect | None | [13] |
Chronic allograft nephropathy | Rat bone marrow | 0.5 × 106 | Intravenous | Immunomodulatory effect | None | [14] |
Renal revascularization | Allogeneic swine adipose tissue | 10 × 106 | Intrarenal | Engraftment/direct effect/paracrine | None | |
Renal artery stenosis | Autologous swine adipose tissue | 10 × 106 | Intrarenal | Engraftment/direct effect/paracrine | None | [15] |